Shearman & Sterling is advising specialty chemicals company LANXESS on its acquisition of the Clean and Disinfect business of US-based chemical company Chemours.
Headquartered in Germany, LANXESS is a leading specialty chemicals company with sales of €7.9 billion in 2015 and about 16,200 employees in 29 countries. The company is currently represented at 52 production sites worldwide.
Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions. Chemours has approximately 8,000 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe.
The Shearman & Sterling team advising on the transaction is led by Global Head of M&A George Casey
(New York-Mergers & Acquisitions) and Heiko Schiwek
(New York-Mergers and Acquisitions) and includes partners Doreen Lilienfeld
(Compensation, Governance & ERISA), Jordan Altman
(New York-Intellectual Property Transactions), Laurence Bambino
(New York-Tax) and Beau Buffier (New York-Antitrust); counsel Jason Pratt
(New York-Environmental) and Robert Fagiola; and associates Greg Gewirtz, Samara Thomas, Maroun El Hachem (New York-Mergers & Acquisitions), David Ling (New York-Compensation, Governance & ERISA), Kelly Karapetyan, Arjun Chandran (New York-Antitrust), JB Betker (New York-Mergers & Acquisitions/Intellectual Property Transactions), Jeffrey Tate (Washington, DC-Tax), Adam Sternberg (New York-Tax) and Kathey Guo (New York-Corporate).